According to market research study published by Gen Consulting Company, the global meningococcal vaccine market is predicted to be growing at a CAGR of over 8.5% from 2021 to 2027.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global meningococcal vaccine market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.
The meningococcal vaccine market is segmented on the basis of serotype, vaccine type, end user, and region. The meningococcal vaccine market is segmented as below:
By serotype:
- MenA vaccine
- MenAC vaccine
- MenACYW vaccine
- MenB/BC vaccine
- MenC vaccine
By vaccine type:
- conjugate meningococcal vaccines
- polysaccharide vaccine
- subcapsular vaccines
By end user:
- adults
- pediatrics
- travelers
By region:
- region
- Asia-Pacific
- Europe
- North America
- Middle East and Africa (MEA)
- South America
The global meningococcal vaccine market is dominated by only a few participants including GlaxoSmithKline Plc., Hualan Biological Engineering Inc., Pfizer inc., Sanofi S.A., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global meningococcal vaccine market.
- To classify and forecast the global meningococcal vaccine market based on serotype, vaccine type, end user, and region.
- To identify drivers and challenges for the global meningococcal vaccine market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global meningococcal vaccine market.
- To conduct pricing analysis for the global meningococcal vaccine market.
- To identify and analyze the profile of leading players operating in the global meningococcal vaccine market.
Why Choose This Report
- Gain a reliable outlook of the global meningococcal vaccine market forecasts from 2021 to 2027 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary
Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints
Part 5. Global market for meningococcal vaccine by serotype
5.1 MenA vaccine
5.1.1 Market size and forecast
5.2 MenAC vaccine
5.2.1 Market size and forecast
5.3 MenACYW vaccine
5.3.1 Market size and forecast
5.4 MenB/BC vaccine
5.4.1 Market size and forecast
5.5 MenC vaccine
5.5.1 Market size and forecast
Part 6. Global market for meningococcal vaccine by vaccine type
6.1 Conjugate meningococcal vaccines
6.1.1 Market size and forecast
6.2 Polysaccharide vaccine
6.2.1 Market size and forecast
6.3 Subcapsular vaccines
6.3.1 Market size and forecast
Part 7. Global market for meningococcal vaccine by end user
7.1 Adults
7.1.1 Market size and forecast
7.2 Pediatrics
7.2.1 Market size and forecast
7.3 Travelers
7.3.1 Market size and forecast
Part 8. Global market for meningococcal vaccine by region
8.1 Asia-Pacific
8.1.1 Market size and forecast
8.2 Europe
8.2.1 Market size and forecast
8.3 North America
8.3.1 Market size and forecast
8.4 Middle East and Africa (MEA)
8.4.1 Market size and forecast
8.5 South America
8.5.1 Market size and forecast
Part 9. Key competitor profiles
9.1 GlaxoSmithKline Plc.
9.2 Hualan Biological Engineering Inc.
9.3 Pfizer inc.
9.4 Sanofi S.A.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY
Executive Summary
Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...
Overview of the Global Vaccine Supply Chain Solutions Market:
The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...
Overview of the Global Digital Vaccine Tracking System Market:
The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...
Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...
Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...
North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...
Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...
The global Whole Cell Cholera Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...
The global Viral Vaccine Media market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The global Vero Cell Rabies Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...